Mark Dalton is an American chief executive and philanthropist. He serves as the chairman and chief executive officer of the Tudor Investment Corporation.[1][2][3]

Early life

Mark Dalton grew up in Detroit, Michigan, and Dayton, Ohio.[4][5] He graduated from Denison University in 1972 and received a JD from Vanderbilt University School of Law in 1975.[1][2][3][6][7]

Business career

Dalton worked as an attorney for Sullivan & Cromwell in New York City, then served as the chief financial officer for Kidder, Peabody & Co. from 1979 to 1988.[1][2][3][4][5][7] In 1988, he joined the Tudor Investment Corporation, and he currently serves as its co-chairman and chief executive officer.[3][5][7] Dalton is also the chief executive officer of Second Management LLC and the sole General partner at D.F. Partners.[2]

Dalton serves on the boards of directors of Progenics Pharmaceuticals and the Cathay Investment Fund.[5][7] He is a member of Advisory Board at Shah Capital Partners.[2]

Philanthropy

Dalton served as the chairman of the board of trustees of Denison University from 2003 to 2009.[1][7][8] He was the chairman of the board of trustees of Vanderbilt University, from 2011 to 2017.[1][6][9]

Dalton serves as chairman of the Sheridan Arts Foundation in Telluride, Colorado.[7][8] He is also a member of the board of directors of the Telluride Foundation and the Buoniconti Fund to Cure Paralysis.[7] Additionally, he is a board member of America's Foundation for Chess.[3] Additionally, together with his wife, he has donated more than US$20,000 to the American Hospital of Paris in Neuilly-sur-Seine.[10]

Personal life

He is married to Susan Dalton, a philanthropist.[8] They have three sons: Erik, Kurt and Chris.[8]

References

No tags for this post.